The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China Idiopathic pulmonary fibrosis ... I ...

Stress-induced cellular senescence, caused by DNA damage ... stroke 3.8 million; chronic obstructive pulmonary disease (COPD) 2.2 million; Alzheimer’s disease 1.0 million; lower respiratory infections ...

Idiopathic pulmonary fibrosis (IPF) is characterized by a progressive decline in lung function, worsening quality of life, and high mortality. However, the rate and pattern of progression of IPF ...

The term “progressive pulmonary fibrosis” or “PPF” is generally used to describe progressive lung fibrosis in an individual with an interstitial lung disease (ILD) other than idiopathic ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...

The research provides a stepping stone toward therapies that can control cellular aging, promoting longer, healthier lives.

The aging and failure of cells that occurs when the liver is damaged can spread to other organs, suggests a new study in mice ...

Researchers challenge longstanding theories in cellular reprogramming Date: November 1, 2024 Source: University of Toronto Summary: A team led by researchers has discovered that a group of cells ...